Shop/BPC-157 5mg
BPC-157 5mg — research compound vial with batch and COA readout Third-Party COA Available
Tissue & Angiogenesis

BPC-157 5mg

SKU: ADL-BPC157-5

Strength

5mg

Purity

99.839% Purity

$20.00

BPC-157 5mg | Lyophilized Powder | RUO. Format: Lyophilized powder. Quantity: 5mg. Purity: Pending COA verification. Storage: -20°C, protect from moisture and light. Stability: 24 months lyophilized. For research use only. Not intended for human or veterinary use. Must be handled by qualified personnel in a proper research setting.

Third-Party COA AvailableEvery product displays verified third-party COA status.

Batch #

ADL-BPC-001

Purity

99.839%

Test Date

2026-07-11

Lab

Kovera Labs

View Full COA
Free Shipping·Next-day OKC local delivery· Payment method selected at checkout

Specifications

CAS Number

137525-51-0

Molecular Formula

C62H98N16O22

Molecular Weight

1419.55 g/mol

Amino Acid Sequence

GEPPPGKPADDAGLV

Nominal Content

5mg

Identity Result

Conforms to reference standard

Storage & Handling

Storage Conditions

-20°C, protect from moisture and light

Research Overview

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a partial sequence of human gastric juice protein BPC. Its molecular structure contains no disulfide bridges, contributing to relative stability under physiological conditions. Researchers study BPC-157 primarily due to its interactions with the nitric oxide (NO) signaling pathway, angiogenic growth factors such as VEGF, and FAK-paxillin signaling involved in cell migration. Preclinical in vitro and rodent-model investigations have examined its influence on fibroblast behavior, collagen organization, and endothelial cell function at the molecular level. BPC-157 is classified as a research compound and has not received regulatory approval for clinical use. All findings referenced here originate from in vitro studies or animal-model experiments. BPC-157 is supplied as a lyophilized research material for laboratory in vitro and analytical use only.

References

  1. [1]
    Sikiric P, Seiwerth S, Rucman R, et al. Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157. Curr Med Chem. 2012;19(1):126-132.
  2. [2]
    Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-780.
  3. [3]
    Tkalcevic VI, Cuzic S, Brajsa K, et al. Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. Eur J Pharmacol. 2007;570(1-3):212-221.
  4. [4]
    Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-1632.
  5. [5]
    Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med. 2017;95(3):323-333.

Related Compounds

Recovery Duo

2-vial kit (5mg + 5mg)

$30.00

Wolverine Blend (BPC-157 / TB-500) 10mg

10mg

$55.00

TB-500 (TB4) 5mg

5mg

$20.00

Resources & Verification

COA Registry

Verify this compound’s batch documentation

FAQ

Common questions about ordering and testing

Research Disclaimer

Important information about research-use-only status

Research Resources

Compound handling, storage, and terminology guide

Related Research Materials — BPC-157 5mg

Research Use Only

All compounds and content on this site are for research use only (RUO). Not for human consumption. For laboratory and research purposes only. Nothing here is medical advice.